A translational pharmacokinetic/pharmacodynamic approach supports optimal vonoprazan dosing for erosive oesophagitis and Helicobacter pylori infection.
Saved in:
| Title: | A translational pharmacokinetic/pharmacodynamic approach supports optimal vonoprazan dosing for erosive oesophagitis and Helicobacter pylori infection. |
|---|---|
| Authors: | Scarpignato C; Department of Health Sciences, United Campus of Malta, Msida, Malta., Howden CW; University of Tennessee College of Medicine, Memphis, Tennessee, USA., Leifke E; Phathom Pharmaceuticals, Research and Development, Buffalo Grove, Illinois, USA., Mulford DJ; Phathom Pharmaceuticals, Research and Development, Buffalo Grove, Illinois, USA., Lahu G; thinkQ2 AG, Oberneuhofstrasse 5, Baar, Switzerland., Facius A; thinkQ2 AG, Oberneuhofstrasse 5, Baar, Switzerland., Hunt R; Department of Medicine, Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada.; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Jul; Vol. 58 (1), pp. 16-25. Date of Electronic Publication: 2023 Apr 17. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2036 |
|---|---|
| DOI: | 10.1111/apt.17510 |
